BIO (BioProtocol) fluctuates 43.7% in 24 hours: Surge in trading volume and synergy with DeSci sector drive movement
Bitget Pulse2026/04/30 13:47Volatility Brief
In the past 24 hours, BIO price rebounded from a low of $0.03218 to a high of $0.04624 and is currently at $0.04004, with a fluctuation range of 43.7%. Trading volume surged to approximately $260 million, more than doubling the normal level, indicating increased capital activity.
Analysis of the Cause of the Volatility
- Abnormal surge in trading volume: In the past 24 hours, there was a 4.1x abnormal buy volume and an overall 2.8x increase in trading volume, driving the price to a rapid rise and testing resistance.
- DeSci/Biotech sector correlation: The market views BIO as a DeSci proxy, and inflows into the sector have been attracted by relaxed peptide regulation and related news (such as the Lilly incident).
Market Views and Outlook
Mainstream community sentiment is cautiously optimistic. Traders are watching the $0.032–$0.034 support level; if it holds and there is a rebound with increased volume, the uptrend may extend to $0.037–$0.040. Conversely, if $0.032 is lost, a pullback to $0.028–$0.030 is possible. Analysts such as Finora AI advise against chasing the rally, recommending entry upon confirmed pullbacks and warning against false breakout risks.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for information reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Intel's stock price plunges 45% in one month; PCs still account for about half of the company's revenue, and foundry customers' confidence is shaken
The ongoing weakness in the Intel PC market and high costs for components such as memory are the main reasons, with the PC business still accounting for about half of total revenue. To alleviate the capacity shortage in data centers, Intel is shifting part of its Oregon factory production from the 18A process to the Intel 3 process, putting foundry trust to the test once again. Experts say that if Intel does not have excess capacity beyond meeting its own needs, it cannot be considered a reliable supplier.
Anthropic’s Q3 revenue growth slows, nearly 900 billion computing power commitment raises financing risks ahead of IPO
Anthropic's revenue growth is slowing, increasing financing risks ahead of its IPO.
Nomura: AI data centers are highly profitable; the downturn in tech stocks is a market “misjudgment”
Nomura stated that the market is misinterpreting Big Tech's negative free cash flow as "AI is not profitable," when in fact, it is a fundamental confusion between the concepts of profit and cash flow. With AWS boasting a profit margin of 38.7% and Google Cloud's year-over-year surge of 103%, cloud business is thriving—negative FCF is merely a timing difference due to the J-curve effect. Nomura bluntly pointed out that if stock prices fall as a result, it would be an excellent entry opportunity for long-term investors.
Crypto prices
More
